Global justice and health systems research in low- and middle-income countries

Journal of Law, Medicine and Ethics

Volumn 43, Issue 1, 2015, Pages 143-161

  Pratt, Bridget ^a,b   Hyder, Adnan A ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPING COUNTRY; ETHICS; HEALTH; HUMAN; MEDICAL RESEARCH; SOCIAL JUSTICE;

BIOMEDICAL RESEARCH; DEVELOPING COUNTRIES; GLOBAL HEALTH; HUMANS; SOCIAL JUSTICE;

EID: 84926385628     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/jlme.12202     Document Type: Article

References (78)

1. S. R. Benatar and P. A. Singer, "A New Look at International Research Ethics, "British Medical Journal 321, no. 7264 (2000): 824-826
2. S. R. Benatar and K. Shapiro, "HIV Prevention Research and Global Inequality: Steps towards Improved Standards of Care, "Journal of Medical Ethics 31, no. 1 (2005): 39-47
3. E. J. Emanuel, "Global Justice and the 'Standard of Care' Debates, "in J. Millum and E. J. Emanuel, eds., Global Justice and Bioethics (Oxford: Oxford University Press): at 181-212
4. A. J. London, "Justice and the Human Development Approach to International Research, "Hastings Center Report 35, no. 1 (2005): 24-37
5. These theories take the position that the scope of justice is global. We recognize that, while there are strong arguments for this claim, it is not universally supported. Anti-cosmopolitan theorists assert that the scope of justice is national and that parties only have obligations of justice to other parties within their nation-states
6. L. Ypi, R. E. Goodin, and C. Barry, "Associative Duties, Global Justice, and the Colonies, "Philosophy and Public Affairs 37, no. 2 (2009): 103-135
7. B. Pratt, D. Zion, and B. Loff, "Evaluating the Capacity of Theories of Justice to Serve as a Justice Framework for International Clinical Research, "American Journal of Bioethics 12, no. 11 (2012): 30-41
8. B. Pratt and B. Loff, "A Framework to Link International Clinical Research to the Promotion of Justice in Global Health, "Bioethics 28, no. 8 (2014): 387-396
9. J. P. Ruger, Health and Social Justice (Oxford: Oxford University Press): at 94-95
10. J. P. Ruger, "Health Capability: Conceptualization and Operationalization, "American Journal of Public Health 100, no. 1 (2010): 41-49
11. As a result, health status can be used as a rough measure of health capability, bearing in mind that it does not fully capture all the elements of health capability.
12. J. P. Ruger, "Global Health Justice, "Public Health Ethics 2, no. 3 (2009): 261-75
13. In this paper, subsequent references to the worst-off refer to those who are worst-off in terms of their health.
14. J. P. Ruger, "Normative Foundations of Global Health Law, "Georgetown Law Journal 96, no. 2 (2008): 423-443
15. Although others have used the terms funder and sponsor interchangeably, we distinguish between the two in this article because, in international research, they are often not the same entity. The sponsoring institution is typically the employer of study investigators rather than the agency from whom funding is awarded. In the Mutuelles trial that we discuss later on, for example, the funder was the Doris Duke Charitable Foundation and the external sponsor was Harvard University.
16. WHO Task Force on Health Systems Research, The Millennium Development Goals will not be Attained without New Research Addressing Health System Constraints to Delivering Effective Interventions (Geneva, Switzerland: WHO, 2005)
17. WHO Task Force on Research Priorities for Equity in Health and the WHO Equity Team, "Priorities for Research to Take Forward the Health Equity Policy Agenda, "Bulletin of the World Health Organization 83 (2005): 948-995
18. Bamako Call to Action on Research for Health, November 17-19, 2008, the Global Ministerial Forum on Research for Health, Bamako, Mali; the Mexico Statement on Health Research, November 16-20, 2004, the Ministerial Summit on Health Research, Mexico City, Mexico.
19. I. Rudan, S. El Arifeen, and R. E. Black et al., "Childhood Pneumonia and Diarrhoea: Setting our Priorities Right, "The Lancet Infectious Diseases 7, no. 1 (2007): 56-61
20. S. Bennett, T. Adam, and C. Zarowsky et al., "From Mexico to Mali: Progress in Health Policy and Systems Research, "The Lancet 372, no. 9649 (2008): 1571-1578
21. A. A. Hyder, A. Rattani, and C. Krubiner et al., "Ethical Review of Health Systems Research in Low and Middle Income Countries: A Conceptual Exploration, "American Journal of Bioethics 14, no. 2 (2014): 28-37
22. World Health Organization, Scaling up Research and Learning for Health Systems: Now Is the Time (Geneva, Switzerland: World Health Organization, 2009
23. L. Gilson, Health Policy and Systems Research: A Methodology Reader (Geneva, Switzerland: Alliance for Health Policy and Systems Research, 2012
24. Some public health research can be considered HSR. Hoffman (13) states that "[t]he overlap [of HSR] with population health research, however, is less clear, but likely includes research on the public health system and the delivery of non-personal public health programs and interventions. Excluded from health systems research would be population health research's focus on measuring or describing health, examining the determinants of health status and outcomes, and assessing the effects of specific health promotion interventions."2012
25. S. Hoffman, J-A. Røttingen, and S. Bennett et al., "Background Paper on Conceptual Issues Related to Health Systems Research to Inform a WHO Global Strategy on Health Systems Research, "2012,http://www.who.int/alliance-hpsr/alliancehpsr_backgroundpaperhsrstrat1.pdf2015
26. This is not to suggest that obligations of justice are not allocated to LMIC research actors. However, identifying the obligations of research actors in LMICs is beyond the scope of this paper. The nature of these obligations should be explored in future work to determine if host country research actors' obligations mirror, overlap, or are distinct from those of external research actors from high-income countries.
27. Alliance for Health Policy and Systems Research (AHPSR), Priority Setting for Health Policy and Systems Research (Geneva, Switzerland: WHO, 2009
28. Council on Health Research for Development (COHRED) and Swedish International Development Cooperation Agency (SIDA), Cameroon: Alignment and Harmonization in Health Research (Geneva, Switzerland: Council on Health Research for Development, 2008)
29. Council on Health Research for Development (COHRED) and Swedish International Development Cooperation Agency (SIDA), Mozambique: Alignment and Harmonization in Health Research (Geneva, Switzerland: Council on Health Research for Development, 2008
30. This was largely due to countries using disease-driven priority setting methods that devalue HSR and then failing to identify HSR priorities through a separate process
31. Council on Health Research for Development (COHRED) and Swedish International Development Cooperation Agency (SIDA), Zambia: Alignment and Harmonization in Health Research (Geneva, Switzerland: Council on Health Research for Development, 2008
32. Council on Health Research for Development (COHRED), Essential National Health Research in South Africa: Towards National Consensus Building in Health Research, 2001http://www.cohred.org/downloads/669.pdf
33. National Institute for Medical Research (NIMR), Tanzania Health Research Priorities, 2006-2010 (Dar es Salaam, Tanzania: National Institute for Medical Research, 2006).
34. This obligation will be discussed in the capacity-building section.
35. M. K. Ranson and S. Bennett, "Priority Setting and Health Policy and Systems Research, "Health Research Policy and Systems 7 (2009): 27
36. Ad Hoc Committee on Health Research Relating to Future Intervention Options, Investing in Health Research and Development (Geneva: World Health Organization, 1996
37. The malERA Consultative Group on Health Systems and Operational Research, "A Research Agenda for Malaria Eradication: Health Systems and Operational Research, "PLoS Medicine e1000397. 8, no. 8 (2011):
38. A. Mills, "Health Care Systems in Low- and Middle-Income Countries, "New England Journal of Medicine 370 (2014): 552-557
39. S. Bennett, I. A. Agyepong, and K. Sheikh et al., "Building the Field of Health Policy and Systems Research: An Agenda for Action, "PLoS Medicine 8, no. 8 (2011): e1001081.
40. J. P. Ruger, "Shared Health Governance, "American Journal of Bioethics 11, no. 7 (2011): 32-45, at 33.
41. C. Wachira and J. P. Ruger, "National Poverty Reduction Strategies and HIV/AIDS Governance in Malawi: A Preliminary Study of Shared Health Governance, "Social Science and Medicine 72, no. 12 (2011): 1956-1964
42. K. Ranson, T. J. Law, and S. Bennett, "Establishing Health Systems Financing Research Priorities in Developing Countries Using a Participatory Methodology, "Social Science and Medicine 70, no. 12 (2010): 1933-1942
43. World Health Organization, The World Health Report - Health Systems Financing: The Path to Universal Coverage (Geneva: World Health Organization, 2010);!! J. Kutzin, "Health Financing for Universal Coverage and Health System Performance: Concepts and Implications for Policy, "Bulletin of the World Health Organization 91 (2013): 602-611
44. Y. Saghai, "Internalized Public Moral Norms and Shared Sovereignty, "American Journal of Bioethics 11, no. 7 (2011): 49-51
45. K. Sheikh, L. Gilson, and I.A. Agyepong et al., "Building the Field of Health Policy and Systems Research: Framing the Questions, "PLoS Medicine 8, no. 8 (2011): e1001073.
46. Rockefeller Foundation, "Catalyzing Change: The System Reform Costs of Universal Health Coverage, "2010http://www.rockefellerfoundation.org/uploads/files/ebafb89b-2d68-45c0-885e-74d40e8c55d9.pdf2015
47. A. Mills, "Health Policy and Systems Research: Defining the Terrain; Identifying the Methods, "Health Policy and Planning 27, no. 1 (2012): 1-7.
48. D. McIntyre and A. Mills, "Research to Support Universal Coverage Reforms in Africa: The SHIELD Project, "Health Policy and Planning 27, Suppl. 1 (2012): i1-i3.
49. K. T. Nguyen, O. T. Khuat, and S. Ma et al., "Impact of Health Insurance on Health Care Treatment and Cost in Vietnam: A Health Capability Approach to Financial Protection, "American Journal of Public Health 102, no. 8 (2012): 1450-1461
50. J. P. Ruger, "An Alternative Framework for Analyzing Financial Protection in Health, "PLoS Medicine 9, no. 8 (2012): e1001294.
51. C. Lu, B. Chin, and J. L. Lewandowski et al., "Towards Universal Health Coverage: An Evaluation of Rwanda Mutuelles in Its First Eight Years, "PLoS One 7, no. 6 (2012): e39282
52. The precise indicators of financial protection proposed by Jennifer Ruger were not relied upon. They had not yet been devised/published.
53. A. A. Hyder, G. Bloom, and M. Leach et al., "Exploring Health Systems Research and Its Influence on Policy Processes in Low Income Countries, "BMC Public Health 7 (2007): 309
54. Global priorities do not necessarily reflect the specific national contexts, as some global priorities may not apply to certain countries (e.g., countries who have already met certain MDG health targets) and certain health problems at the national level may not be included on the list of global priorities.
55. A. A. Hyder, A. Corluka, and P. J. Winch et al., "National Policy-Makers Speak Out: Are Researchers Giving Them What They Need?" Health Policy and Planning 26, no. 1 (2011): 73-82
56. S. Bennett, L. Paina, and C. Kim et al., "What Must be Done to Enhance Capacity for Health Systems Research?" 2010http://www.rockefellerfoundation.org/uploads/files/c4ccb675-f6f8-47de-8552-e032d4c3fc20.pdf2015
57. P. R. Hotez, C. Cohen, and T. Mimura et al., Strengthening Mechanisms to Prioritize, Coordinate, Finance, and Execute R&D to Meet Health Needs in Developing Countries (Washington, D.C.: Institute of Medicine, 2013). This is not to say all development agencies view research and research capacity strengthening as falling outside their remit. A 2001 Overseas Development Institute report that mapped research capacity strengthening initiatives in LMICs identified funding streams available at the following agencies: the Danish International Development Agency (DANIDA), the Swedish International Development Cooperation Agency (SIDA)'s Department for Research Cooperation (SAREC), and Canada's International Development Research Centre (IDRC). The United Kingdom's Department for International Development also views research capacity strengthening as being part of its remit and funds both HSR and clinical research in LMICs
58. J. Young and N. Kannemeyer, Building Capacity in Southern Research: A Study to Map Existing Initiatives (London, United Kingdom: Overseas Development Institute, 2001
59. Department for International Development (DFID), Capacity Building in Research, 2010http://bsuhh.org/fileadmin/user_upload/bsu-ge/Other_Reports/How_To_Note_Research_Capacity_Building.pdf
60. Department for International Development (DFID), DFID Research Strategy 2008-2013 Working Paper Series: Capacity Building (London, United Kingdom: Department for International Development, 2008
61. Research funders that do not have a role in development and solely channel their resources to research also have an obligation to fund HSR capacity strengthening that occurs during research-related activities (i.e., institutional collaborations and research projects). They do not have an obligation to fund systems level strengthening.
62. P. Basinga, P. J. Gertler, and A. Binagwaho et al., "Effect on Maternal and Child Health Services in Rwanda of Payment to Primary Health-Care Providers for Performance: an Impact Evaluation, "The Lancet 377, no. 9775 (2011): 1421-1428
63. During the research project, this responsibility is generally met by the research funder.
64. H. H. Koh, S. C. Oppenheimer, S. B. Massin-Short et al., "Translating Research Evidence into Practice to Reduce Health Disparities: A Social Determinants Approach, "American Journal of Public Health 100, Suppl. 1 (2010): S72-S80
65. F. Ssengooba, L. Atuyambe, and S. N. Kiwanuka et al., "Research Translation to Inform National Health Policies: Learning from Multiple Perspectives in Uganda, "BMC International Health and Human Rights 11, Suppl 1. (2011): S13
66. E. Ekirapa-Kiracho, P. Waiswa, and M. Hafizur Rahman et al., "Increasing Access to Institutional Deliveries Using Demand and Supply Side Incentives: Early Results from a Quasi-Experimental Study, "BMC International Health and Human Rights, 11, Supp. 1 (2011): S11.
67. G. Pariyo, C. Mayora, and O. Okui et al., "Exploring New Health Markets: Experiences from Informal Providers of Transport for Maternal Health Services in Eastern Uganda, "BMC International Health and Human Rights, 11, Supp. 1 (2011):
68. Here, the framework calls for the handover of intervention implementation to local actors or international NGOs (working with local actors) that are involved in health programming and/or health system strengthening. Their delivery of interventions is supported by funding from aid agency, global health organisation, and/or philanthropic foundation donors (see Obligation-Bearers sub-section).
69. A. A. Hyder, G. Bloom, and M. Leach et al., "Exploring Health Systems Research and Its Influence on Policy Processes in Low Income Countries, "BMC Public Health 7 (2007): 309
70. J. N. Orem, D. K. Mafigiri, and B. Marchal et al., "Research, Evidence and Policymaking: The Perspectives of Policy Actors on Improving Uptake of Evidence in Health Policy Development and Implementation in Uganda, "BMC Public Health 12 (2010): 109
71. F. El-Jardali, J. N. Lavis, and N. Ataya et al., "Use of Health Systems Evidence by Policymakers in Eastern Mediterranean Countries: Views, Practices, and Contextual Influences, "BMC Health Services Research 12 (2012): 200.
72. K. Jönsson, G. Tomson, and C. Jönsson et al., "Health Systems Research in Lao PDR: Capacity Development for Getting Research into Policy and Practice, "Health Research and Policy Systems 5 (2007): 11
73. These units would focus on getting successful systems-level interventions implemented, unlike technology transfer offices, which focus solely on the commercialisation of new medical technologies.
74. HSR funders that only have a role in research have a narrower obligation to support the provision of post-study benefits. They should support grants for long-term programs of HSR that span system performance assessments to intervention development. Where applicants to funding schemes for HSR propose to evaluate an intervention, they should be required to design and execute an intervention implementation strategy during projects and be permitted to request budget allocations to support this.
75. K. Schmidt, "The Missing Link: The Global Fund and Financial Access to Health Care, "2010http://www.rockefellerfoundation.org/uploads/files/6485982c-b708-4cc5-af99-ef411035a0f4-gfatm-support.pdf
76. B. Pratt and B. Loff, "Health Research Systems: Promoting Health Equity or Economic Competitiveness?" Bulletin of the World Health Organization 90 (2012): 55-62
77. J. P. Ruger, "Author Response to Letter to the Editor: Making Power Visible in Global Health Governance, "American Journal of Bioethics 12, no. 7 (2012): 65
78. A. G. Mitra, "A Social Connection Model for International Clinical Research, "American Journal of Bioethics 13, no. 3 (2013): W1-W3